Effect of Global Longitudinal Strain at Discharge Period on Predicting Cardiac Defibrillator Implantation in STEMİ

Ömer Ferudun Akkuş1, Muhammet Gürdoğan1

  • 1Department of Cardiology, School of Medicine, Trakya University, 22030 Edirne, Turkey.

PubMed

Insights

Low left ventricular global longitudinal strain (GLS) measured at discharge can predict low ejection fraction (EF) in STEMI patients. This finding may help identify high-risk individuals earlier for timely intervention.

Area of Science:

  • Cardiology
  • Cardiac Imaging
  • Heart Failure Research

Background:

  • Low ejection fraction (EF) predicts sudden cardiac death in ischemic heart failure.
  • Current guidelines recommend a 90-day wait for implantable cardioverter-defibrillator (ICD) in STEMI patients, which may be insufficient for preventing sudden death.

Purpose of the Study:

  • To determine if left ventricular global longitudinal strain (GLS) at discharge can predict EF < 35% at 3-month follow-up in STEMI patients.
  • To identify high-risk STEMI patients earlier for potential reduction in ICD implantation waiting time.

Main Methods:

  • Prospective study involving 69 STEMI patients with impaired systolic function.
  • Echocardiographic imaging to measure LV GLS at discharge.
  • Comparison of GLS in patients with EF ≤ 35% versus EF 36-49% at 3 months.

Main Results:

  • LV GLS at discharge was the sole independent predictor of EF ≤ 35% at 3 months.
  • A GLS value < 9.55% at discharge predicted EF < 35% at 90 days (Sensitivity 75%, Specificity 76.5%, AUC 0.814, p=0.005).

Conclusions:

  • Low LV GLS at discharge is a significant early predictor of reduced EF in STEMI patients.
  • GLS may enable earlier identification of high-risk patients, potentially shortening the waiting period for ICD implantation.

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...